ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Illinois » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Illinois

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
THOMAS TSE M.D.

Endocrinology, Diabetes Metabolism

16,625

$1.19M

577
370 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

15%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 45%

$72
Average prescription price

Avg: $125

RAMESHKUMAR RAMAN M.D.

Endocrinology, Diabetes Metabolism

10,465

$1.51M

828
603 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 45%

$144
Average prescription price

Avg: $125

SATISH VIJ MD

Endocrinology, Diabetes Metabolism

9,671

$577K

290
133 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 45%

$60
Average prescription price

Avg: $125

ISSA ABEDMAHMOUD MD

Endocrinology, Diabetes Metabolism

7,255

$987K

536
324 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 45%

$136
Average prescription price

Avg: $125

PAUL RUESTOW M.D.

Endocrinology, Diabetes Metabolism

7,163

$330K

444
376 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 45%

$46
Average prescription price

Avg: $125

WASSIM EL-HARAKE M.D.

Endocrinology, Diabetes Metabolism

7,034

$607K

466
324 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 45%

$86
Average prescription price

Avg: $125

GRANT SIEVERTSEN MD

Endocrinology, Diabetes Metabolism

7,007

$600K

497
440 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 45%

$86
Average prescription price

Avg: $125

DAVID BALDWIN M.D.

Endocrinology, Diabetes Metabolism

6,919

$706K

367
229 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 45%

$102
Average prescription price

Avg: $125

MICHAEL OLDEN D.O.

Endocrinology, Diabetes Metabolism

6,554

$628K

350
264 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 45%

$96
Average prescription price

Avg: $125

SAIMA ALI M.D.

Endocrinology, Diabetes Metabolism

6,488

$425K

326
262 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 45%

$66
Average prescription price

Avg: $125

ALAN REICH MD

Endocrinology, Diabetes Metabolism

5,389

$853K

497
435 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 45%

$158
Average prescription price

Avg: $125

JOHN HOVIS MD

Endocrinology, Diabetes Metabolism

5,354

$859K

498
324 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

55%
prescriptions for brand name drugs

Avg: 45%

$160
Average prescription price

Avg: $125

CHAIYAPON COUROPMITREE MD

Endocrinology, Diabetes Metabolism

5,331

$459K

217
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

18%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 45%

$86
Average prescription price

Avg: $125

DAVID OYER M.D.

Endocrinology, Diabetes Metabolism

5,083

$638K

282
258 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 45%

$126
Average prescription price

Avg: $125

NIDAL HASAN MD

Endocrinology, Diabetes Metabolism

4,907

$364K

287
187 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 45%

$74
Average prescription price

Avg: $125

FREDRICK ELLYIN M.D.,FACP,FCP,FACE

Endocrinology, Diabetes Metabolism

4,899

$503K

173
136 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 45%

$103
Average prescription price

Avg: $125

THOMAS PITTS M.D.

Endocrinology, Diabetes Metabolism

4,871

$397K

245
207 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 45%

$81
Average prescription price

Avg: $125

A. MATHEW M.D.

Endocrinology, Diabetes Metabolism

4,806

$254K

216
160 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 45%

$53
Average prescription price

Avg: $125

JAYSHREE DHALI M.D.

Endocrinology, Diabetes Metabolism

4,724

$390K

273
203 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 45%

$83
Average prescription price

Avg: $125

TERRENCE SWADE M.D.

Endocrinology, Diabetes Metabolism

4,670

$515K

354
318 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 45%

$110
Average prescription price

Avg: $125

PAUL WILSON MD

Endocrinology, Diabetes Metabolism

4,532

$289K

275
233 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 45%

$64
Average prescription price

Avg: $125

DANIEL SO M.D.

Endocrinology, Diabetes Metabolism

4,445

$776K

436
359 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 45%

$175
Average prescription price

Avg: $125

GERALD CHARNOGURSKY MD

Endocrinology, Diabetes Metabolism

4,399

$518K

302
227 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 45%

$118
Average prescription price

Avg: $125

DEAN KRAVIS MD

Endocrinology, Diabetes Metabolism

4,346

$400K

279
236 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 45%

$92
Average prescription price

Avg: $125

SHUJAUDDIN VALIKA M.D.

Endocrinology, Diabetes Metabolism

4,249

$528K

384
299 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 45%

$124
Average prescription price

Avg: $125

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank